Tyrosine kinase inhibitors: rationale, mechanisms of action, and implications for drug resistance. [electronic resource]
Producer: 20011228Description: 47-55 p. digitalISSN:- 0093-7754
- Animals
- Antineoplastic Agents -- pharmacology
- Breast Neoplasms -- drug therapy
- Cell Cycle -- drug effects
- Clinical Trials as Topic
- Drug Evaluation, Preclinical
- Drug Resistance, Neoplasm
- Enzyme Inhibitors -- pharmacology
- Humans
- Ligands
- Neoplasms, Glandular and Epithelial -- drug therapy
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Receptor Protein-Tyrosine Kinases -- antagonists & inhibitors
- Receptor, ErbB-2 -- antagonists & inhibitors
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review
There are no comments on this title.
Log in to your account to post a comment.